貓大師：紐約時報的文章大肆鼓吹ARNA的減肥藥？見內

Lorcaserin, from Arena Pharmaceuticals, works on the brain to control appetite in the same way as fenfluramine, the fen-phen component that was withdrawn from the market for damaging heart valves. But trials so far indicate that lorcaserin does not cause the heart valve problem.

And a potential advantage for lorcaserin is that it is a new drug and so would not face potential competition from generics.

這一下子ARNA要奔向20啦？

您老貓大師實在是神靈無窮啊？

PF,PF